Nested matched case control study for the Japan Fukushima Health Management Survey's first full-scale (second-round) thyroid examination.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
02 Jul 2020
Historique:
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 18 7 2020
Statut: ppublish

Résumé

Since Fukushima nuclear accident in 2011, thyroid ultrasound examinations have been conducted. The first full-scale examination detected 71 thyroid-cancer cases. This study examined whether radiation exposure was associated with thyroid-cancer incidence.Subjects were participants in the baseline screening and newborns during the 2011 fiscal year. Under nested matched case-control study design, 10 controls per each case were selected by matching the age, sex, baseline screening results, and interval between examinations. With 3 dose levels of external radiation: 1.3 + mSv (upper), 0.8 to 1.3 (middle), and 0.0 to 0.8 (reference), we applied 2 logistic models adjusting for 3 participation-proportions (primary, secondary, and fine-needle aspiratory cytology), overweight, and the B-result of baseline screening (Model 1), and past medical history, family history of thyroid cancer, and frequencies of eating seafood and seaweed in addition to the parameters in Model 1 (Model 2). We examined each model in 3 ways: (a) excluding subjects with a missing radiation exposure dose; and substituting (b1) median or (b2) mean dose of the municipality with missing dose.Odds ratios (ORs) of middle-dose exposure were (a) 1.35 (0.46-3.94), (b1) 1.55 (0.61-3.96), and (b2) 1.23 (0.50-3.03) for Model 1, and (a) 1.18 (0.39-3.57), (b1) 1.31 (0.49-3.49), and (b2) 1.02 (0.40-2.59) for Model 2. For upper-dose exposure, similar results were obtained. Past medical history was significantly associated (odds ratio  = 2.04-2.08) with both (b1) and (b2) in Model 2.No significant associations were obtained between the external radiation exposure and thyroid-cancer incidence.

Identifiants

pubmed: 32629628
doi: 10.1097/MD.0000000000020440
pii: 00005792-202007020-00007
pmc: PMC7337421
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e20440

Références

J Epidemiol. 2012;22(5):375-83
pubmed: 22955043
Jpn J Clin Oncol. 2015 Sep;45(9):884-91
pubmed: 26142437
Jpn J Clin Oncol. 2016 Mar;46(3):284-6
pubmed: 26755830
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2575-2583
pubmed: 28323979
Int J Cancer. 2018 Nov 1;143(9):2145-2149
pubmed: 29355960
Radiat Prot Dosimetry. 2012 Sep;151(3):489-99
pubmed: 22416255
Proc Jpn Acad Ser B Phys Biol Sci. 2015;91(3):92-8
pubmed: 25765011
Medicine (Baltimore). 2016 Aug;95(35):e4472
pubmed: 27583855
Radiat Res. 2006 Jan;165(1):1-8
pubmed: 16392956
J Clin Endocrinol Metab. 2018 Mar 1;103(3):861-869
pubmed: 29253182
Sci Rep. 2018 Dec 5;8(1):17661
pubmed: 30518765
Epidemiology. 2016 May;27(3):316-22
pubmed: 26441345
Medicine (Baltimore). 2017 Dec;96(48):e8631
pubmed: 29310337
Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(4):157-63
pubmed: 23574806
Epidemiology. 2018 Jul;29(4):e32-e34
pubmed: 29634592
Sci Rep. 2013;3:1670
pubmed: 23591638
J Radiat Res. 2016 Aug;57 Suppl 1:i118-i126
pubmed: 27538842
Sci Rep. 2015 Aug 04;5:12712
pubmed: 26239643
Nature. 1992 Sep 3;359(6390):21
pubmed: 1522879
J Radiol Prot. 2017 Sep 25;37(3):584-605
pubmed: 28617669
Clin Pediatr Endocrinol. 2011 Apr;20(2):47-9
pubmed: 23926394

Auteurs

Hideto Takahashi (H)

National Institute of Public Health, Saitama.
Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.

Seiji Yasumura (S)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Public Health, Fukushima Medical University School of Medicine, Fukushima.

Kunihiko Takahashi (K)

Department of Biostatistics M&D Data Science Center Tokyo Medical and Dental University.

Tetsuya Ohira (T)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Epidemiology.

Akira Ohtsuru (A)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Radiation Health Management.

Sanae Midorikawa (S)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Radiation Health Management.

Satoru Suzuki (S)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.

Hiroki Shimura (H)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Laboratory Medicine.

Tetsuo Ishikawa (T)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Radiation Physics and Chemistry.

Akira Sakai (A)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Radiation Life Sciences.

Shinichi Suzuki (S)

Department of Thyroid and Endocrinology, Fukushima Medical University School of Medicine.

Susumu Yokoya (S)

Thyroid and Endocrine Center, Fukushima Medical University, Fukushima.

Koichi Tanigawa (K)

Fukushima Global Medical Science Center, Fukushima Medical University.

Hitoshi Ohto (H)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.

Kenji Kamiya (K)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH